Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For CFG
Valuation Somewhat Positive
56%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Bad
0%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -99.83 0.14 84.80
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 757.08 -55.21 6.44
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -1.36 51.50 52.21
Cash 4.44 93.42 89.44
Capex 78.95 -0.02 -0.10
Free Cash Flow -39.40 0.81 1.33
Revenue 60.89 6.86 4.26
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -0.20 0.99 0.99
Operating Margin 55.41 0.14 0.09
ROA 77.93 < 0.005 < 0.005
ROE 81.04 0.01 < 0.005
ROIC 112.56 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of CFG is permitted for members.
5 Growth
The "Growth Entry" for the Focus of CFG is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of CFG is permitted for members.